The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Paul Chapman; Lee Cranmer; W. G. Dixon; K. L. Hyrich; John R. Patterson; D. P M Symmons; Mary Toporcer; Michael J. Mastrangelo

doi:10.1053/j.seminoncol.2010.01.001

The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Paul Chapman, Lee Cranmer, W. G. Dixon, K. L. Hyrich, John R. Patterson, D. P M Symmons, Mary Toporcer, Michael J. Mastrangelo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	11-19
Number of pages	8
Journal	Seminars in Oncology
Volume	37
Issue number	1
DOIs	https://doi.org/10.1053/j.seminoncol.2010.01.001
Publication status	Published - Feb 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/j.seminoncol.2010.01.001

Cite this

@article{539a15af10ba41a5ab7c8a64edc606ec,

title = "The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?",

author = "Paul Chapman and Lee Cranmer and Dixon, {W. G.} and Hyrich, {K. L.} and Patterson, {John R.} and Symmons, {D. P M} and Mary Toporcer and Mastrangelo, {Michael J.}",

year = "2010",

month = feb,

doi = "10.1053/j.seminoncol.2010.01.001",

language = "English",

volume = "37",

pages = "11--19",

journal = "Seminars in Oncology",